146 related articles for article (PubMed ID: 9652836)
1. Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer.
Miura M; Takeda M; Sasaki T; Inoue T; Nakayama T; Fukuda H; Hoshi A; Hoshina M; Shibuya H
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):763-70. PubMed ID: 9652836
[TBL] [Abstract][Full Text] [Related]
2. Techniques for making spacers in interstitial brachytherapy for tongue cancer.
Tamamoto M; Fujita M; Yamamoto T; Hamada T
Int J Prosthodont; 1996; 9(1):95-8. PubMed ID: 8630183
[TBL] [Abstract][Full Text] [Related]
3. Dose-reducing effect of Lipowitz metal-embedded spacers in interstitial brachytherapy for carcinoma of the mobile tongue.
Fujita M; Hirokawa Y; Tamamoto M; Kashiwado K; Akagi Y; Kashimoto K; Wada T
Oral Surg Oral Med Oral Pathol; 1994 Jun; 77(6):589-93. PubMed ID: 8065721
[TBL] [Abstract][Full Text] [Related]
4. Design of the spacer for brachytherapy using
Suenaga H; Tamahara T; Dodo M; Murakami T; Sasaki S; Ito K; Jingu K; Koseki T; Sasaki K
J Prosthodont Res; 2018 Oct; 62(4):518-521. PubMed ID: 30082221
[TBL] [Abstract][Full Text] [Related]
5. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of tooth extraction and osteoradionecrosis after low-dose rate brachytherapy for patients with tongue cancer.
Konishi M; Shimabukuro K; Kakimoto N
Oral Radiol; 2024 Apr; 40(2):158-164. PubMed ID: 37831428
[TBL] [Abstract][Full Text] [Related]
7. Clinical study of a spacer to help prevent osteoradionecrosis resulting from brachytherapy for tongue cancer.
Obinata K; Ohmori K; Tuchiya K; Nishioka T; Shirato H; Nakamura M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):246-50. PubMed ID: 12582367
[TBL] [Abstract][Full Text] [Related]
8. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
[TBL] [Abstract][Full Text] [Related]
9. Preventing Complications from High-Dose Rate Brachytherapy when Treating Mobile Tongue Cancer via the Application of a Modular Lead-Lined Spacer.
Murakami S; Verdonschot RG; Kakimoto N; Sumida I; Fujiwara M; Ogawa K; Furukawa S
PLoS One; 2016; 11(4):e0154226. PubMed ID: 27128434
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of a radiolucent spacer in radiation therapy for cancer of the tongue].
Niwa K; Morita K; Kanazawa H; Yokoi M
Gan No Rinsho; 1984 Dec; 30(15):1861-5. PubMed ID: 6441853
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.
Lee IJ; Koom WS; Lee CG; Kim YB; Yoo SW; Keum KC; Kim GE; Choi EC; Cha IH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1084-91. PubMed ID: 19327914
[TBL] [Abstract][Full Text] [Related]
12. Brachytherapy as part of the definitive management of squamous cancer of the base of tongue.
Harrison LB; Sessions RB; Strong EW; Fass DE; Nori D; Fuks Z
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1309-12. PubMed ID: 2599912
[TBL] [Abstract][Full Text] [Related]
13. A new, simple method of making a spacer in interstitial brachytherapy for mobile tongue cancer.
Yuasa K; Kawazu T; Morita M; Uehara S; Kunitake N; Kanda S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Apr; 89(4):519-21. PubMed ID: 10760736
[TBL] [Abstract][Full Text] [Related]
14. Osteoradionecrosis of the mandible. Comparison of the effects of external beam irradiation and brachytherapy.
Støre G; Evensen J; Larheim TA
Dentomaxillofac Radiol; 2001 Mar; 30(2):114-9. PubMed ID: 11313733
[TBL] [Abstract][Full Text] [Related]
15. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques.
Pernot M; Malissard L; Aletti P; Hoffstetter S; Forçard JJ; Bey P
Radiother Oncol; 1992 Apr; 23(4):223-8. PubMed ID: 1609126
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma.
Ozyar E; Yildz F; Akyol FH; Atahan IL
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):101-8. PubMed ID: 11777627
[TBL] [Abstract][Full Text] [Related]
17. [Time, dose and volume factors in interstitial brachytherapy combined with external irradiation for oral tongue carcinoma].
Yorozu A
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Apr; 56(5):303-10. PubMed ID: 8692656
[TBL] [Abstract][Full Text] [Related]
18. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
[TBL] [Abstract][Full Text] [Related]
19. Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy.
Notani K; Yamazaki Y; Kitada H; Sakakibara N; Fukuda H; Omori K; Nakamura M
Head Neck; 2003 Mar; 25(3):181-6. PubMed ID: 12599284
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation.
Mazeron JJ; Crook JM; Marinello G; Walop W; Pierquin B
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):281-5. PubMed ID: 2394607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
